Oaklins begleitete 2025 insgesamt 36 M&A-Transaktionen im Healthcare-Sektor, über Life Sciences, MedTech, Healthcare Providers und Healthcare Techn...
Read article
Switzerland Switzerland Oaklins begleitete 2025 insgesamt 36 M&A-Transaktionen im Healthcare-Sektor, über Life Sciences, MedTech, Healthcare Providers und Healthcare Techn...
Read articleHealthcare M&A remains stable. Outpatient models, digitalisation and scale define the next growth phase. Our Q3 update highlights key trends, valua...
Read articleThe contract pharma market is reshaping around scale, specialization, and regulatory trust. Swiss and DACH-based CROs/CDMOs are drawing strong inve...
Read articleIn our MedTech M&A-Report, you will find updates on M&A activities and company valuations, current trends and an outlook on upcoming developments i...
Read articleIn our MedTech M&A-Report, you will find updates on M&A activities and company valuations, current trends and an outlook on upcoming developments i...
Read article